Alzheimer’s Association launches $20million study to reduce dementia risk

21 July 2017 – The Alzheimer’s Association has announced the launch of a landmark clinical trial into the effect of multi-dimensional lifestyle interventions to prevent cognitive decline and dementia in the USA.

Announced at the Alzheimer’s Association International Conference in London, the 20-million-dollar-study is modelled on the landmark Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), and follows presentations of findings from major lifestyle studies in Australia and Singapore in 2017.

The large study, PrOtect through a lifestyle INTErvention to Reduce risk (US POINTER), will examine the effect of physical exercise, nutritional counselling, cognitive and social stimulation, and improved self-management of medical conditions on 2,500 individuals at higher risk of cognitive decline and dementia between the ages of 60 and 79 years old.

Findings of the study will be based on changes over two years in measurements of cognitive function that include short-term memory, attention and concentration and will provide an important resource for future research into the prevention of dementia globally. Dementia will affect 75 million people worldwide by 2030. Large scale trials are critical to enhance knowledge of risks and prevention, including new data on other factors in the progression of the disease in different populations and contexts. 

Recruitment for the study will begin in 2018, supported by local chapters of the Alzheimer’s Association across the US.

Where next?